• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫苗接种后 COVID-19 住院的风险因素:加拿大基于人群的队列研究。

Risk factors for COVID-19 hospitalization after COVID-19 vaccination: a population-based cohort study in Canada.

机构信息

Data and Analytic Services, British Columbia Centre for Disease Control, Vancouver, Canada; School of Population and Public Health, University of British Columbia, Vancouver, Canada.

Data and Analytic Services, British Columbia Centre for Disease Control, Vancouver, Canada; School of Population and Public Health, University of British Columbia, Vancouver, Canada.

出版信息

Int J Infect Dis. 2023 Feb;127:116-123. doi: 10.1016/j.ijid.2022.12.001. Epub 2022 Dec 9.

DOI:10.1016/j.ijid.2022.12.001
PMID:36503044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9731811/
Abstract

OBJECTIVES

With the uptake of COVID-19 vaccines, there is a need for population-based studies to assess risk factors for COVID-19-related hospitalization after vaccination and how they differ from unvaccinated individuals.

METHODS

We used data from the British Columbia COVID-19 Cohort, a population-based cohort that includes all individuals (aged ≥18 years) who tested positive for SARS-CoV-2 by real-time reverse transcription-polymerase chain reaction from January 1, 2021 (after the start of vaccination program) to December 31, 2021. We used multivariable logistic regression models to assess COVID-19-related hospitalization risk by vaccination status and age group among confirmed COVID-19 cases.

RESULTS

Of the 162,509 COVID-19 cases included in the analysis, 8,546 (5.3%) required hospitalization. Among vaccinated individuals, an increased odds of hospitalization with increasing age was observed for older age groups, namely those aged 50-59 years (odds ratio [OR] = 2.95, 95% confidence interval [CI]: 2.01-4.33), 60-69 years (OR = 4.82, 95% CI: 3.29, 7.07), 70-79 years (OR = 11.92, 95% CI: 8.02, 17.71), and ≥80 years (OR = 24.25, 95% CI: 16.02, 36.71). However, among unvaccinated individuals, there was a graded increase in odds of hospitalization with increasing age, starting at age group 30-39 years (OR = 2.14, 95% CI: 1.90, 2.41) to ≥80 years (OR = 41.95, 95% CI: 35.43, 49.67). Also, comparing all the age groups to the youngest, the observed magnitude of association was much higher among unvaccinated individuals than vaccinated ones.

CONCLUSION

Alongside a number of comorbidities, our findings showed a strong association between age and COVID-19-related hospitalization, regardless of vaccination status. However, age-related hospitalization risk was reduced two-fold by vaccination, highlighting the need for vaccination in reducing the risk of severe disease and subsequent COVID-19-related hospitalization across all population groups.

摘要

目的

随着 COVID-19 疫苗的普及,需要进行基于人群的研究来评估接种疫苗后 COVID-19 相关住院的风险因素,以及这些因素与未接种疫苗者的不同之处。

方法

我们使用了不列颠哥伦比亚 COVID-19 队列的数据,这是一个基于人群的队列,其中包括所有在 2021 年 1 月 1 日(疫苗接种计划开始后)至 2021 年 12 月 31 日期间通过实时逆转录聚合酶链反应检测出 SARS-CoV-2 呈阳性的个体(年龄≥18 岁)。我们使用多变量逻辑回归模型,根据疫苗接种状况和确诊 COVID-19 病例的年龄组评估 COVID-19 相关住院的风险。

结果

在纳入分析的 162509 例 COVID-19 病例中,有 8546 例(5.3%)需要住院治疗。在接种疫苗的个体中,随着年龄的增长,住院的几率也随之增加,尤其是 50-59 岁年龄组(比值比[OR] = 2.95,95%置信区间[CI]:2.01-4.33)、60-69 岁年龄组(OR = 4.82,95% CI:3.29-7.07)、70-79 岁年龄组(OR = 11.92,95% CI:8.02-17.71)和≥80 岁年龄组(OR = 24.25,95% CI:16.02-36.71)。然而,在未接种疫苗的个体中,随着年龄的增长,住院的几率呈梯度增加,从 30-39 岁年龄组(OR = 2.14,95% CI:1.90-2.41)开始增加,直到≥80 岁年龄组(OR = 41.95,95% CI:35.43-49.67)。此外,将所有年龄组与最年轻的年龄组进行比较,未接种疫苗个体的观察到的关联程度明显高于接种疫苗个体。

结论

除了一些合并症外,我们的研究结果表明,年龄与 COVID-19 相关住院之间存在很强的关联,无论接种疫苗状况如何。然而,疫苗接种将住院风险降低了两倍,这突出表明,在所有人群中,疫苗接种对于降低严重疾病和随后的 COVID-19 相关住院风险至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d282/9731811/7cd8fdf46bb5/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d282/9731811/7cd8fdf46bb5/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d282/9731811/7cd8fdf46bb5/gr1_lrg.jpg

相似文献

1
Risk factors for COVID-19 hospitalization after COVID-19 vaccination: a population-based cohort study in Canada.新冠疫苗接种后 COVID-19 住院的风险因素:加拿大基于人群的队列研究。
Int J Infect Dis. 2023 Feb;127:116-123. doi: 10.1016/j.ijid.2022.12.001. Epub 2022 Dec 9.
2
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.COVID-19 病例和住院情况按 COVID-19 疫苗接种状况和既往 COVID-19 诊断情况划分-加利福尼亚州和纽约州,2021 年 5 月至 11 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):125-131. doi: 10.15585/mmwr.mm7104e1.
3
Association of COVID-19 Infection With Incident Diabetes.COVID-19 感染与新发糖尿病的关联。
JAMA Netw Open. 2023 Apr 3;6(4):e238866. doi: 10.1001/jamanetworkopen.2023.8866.
4
Risk of Severe COVID-19-Related Outcomes among Patients with Cirrhosis: A Population-Based Cohort Study in Canada.肝硬化患者发生严重 COVID-19 相关结局的风险:加拿大基于人群的队列研究。
Viruses. 2024 Feb 24;16(3):351. doi: 10.3390/v16030351.
5
Vaccine effectiveness against severe COVID-19 outcomes within the French overseas territories: A cohort study of 2-doses vaccinated individuals matched to unvaccinated ones followed up until September 2021 and based on the National Health Data System.疫苗对法国海外领土内严重 COVID-19 结局的有效性:一项基于国家卫生数据系统的 2 剂接种者与未接种者匹配的队列研究,随访至 2021 年 9 月。
PLoS One. 2022 Sep 9;17(9):e0274309. doi: 10.1371/journal.pone.0274309. eCollection 2022.
6
SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.2021 年 5 月 1 日至 7 月 25 日,加利福尼亚州洛杉矶县≥16 岁人群中,根据疫苗接种状况划分的 SARS-CoV-2 感染和住院情况。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1170-1176. doi: 10.15585/mmwr.mm7034e5.
7
Real-world study of the effectiveness of BBIBP-CorV (Sinopharm) COVID-19 vaccine in the Kingdom of Morocco.摩洛哥王国 BBIBP-CorV(国药)新冠病毒疫苗真实世界研究的有效性。
BMC Public Health. 2022 Aug 20;22(1):1584. doi: 10.1186/s12889-022-14016-9.
8
SARS-CoV-2 vaccination, ABO blood group and risk of COVID-19: population-based cohort study.SARS-CoV-2 疫苗接种、ABO 血型与 COVID-19 风险:基于人群的队列研究。
BMJ Open. 2022 Jul 18;12(7):e059944. doi: 10.1136/bmjopen-2021-059944.
9
Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National Population.高风险人群中突破性严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染的完全接种疫苗者发生重症/危重症的比例和危险因素。
Clin Infect Dis. 2022 Aug 24;75(1):e849-e856. doi: 10.1093/cid/ciab1023.
10
Vaccination status among patients with the need for emergency hospitalizations related to COVID-19.与 COVID-19 相关的急诊住院患者的疫苗接种状况。
Am J Emerg Med. 2022 Apr;54:102-106. doi: 10.1016/j.ajem.2022.01.067. Epub 2022 Feb 3.

引用本文的文献

1
SARS-CoV-2 vaccination influence in the development of long-COVID clinical phenotypes.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)疫苗接种对长期新冠临床表型发展的影响。
Epidemiol Infect. 2025 Feb 4;153:e40. doi: 10.1017/S0950268825000093.
2
The mediating role of SARS-CoV-2 variants between income and hospitalization due to COVID-19: a period-based mediation analysis.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株在收入与新冠病毒病(COVID-19)住院之间的中介作用:基于时期的中介分析
Am J Epidemiol. 2025 May 7;194(5):1352-1361. doi: 10.1093/aje/kwae266.
3
GDF-15 Levels and Other Laboratory Findings as Predictors of COVID-19 Severity and Mortality: A Pilot Study.
生长分化因子-15水平及其他实验室检查结果作为COVID-19严重程度和死亡率预测指标的初步研究
Biomedicines. 2024 Mar 29;12(4):757. doi: 10.3390/biomedicines12040757.
4
Characteristics and clinical outcomes of nirmatrelvir/ritonavir (Paxlovid) recipients in Canada, 2022: a descriptive cohort study.2022年加拿大接受奈玛特韦/利托那韦(帕罗韦德)治疗者的特征与临床结局:一项描述性队列研究
Can Commun Dis Rep. 2023 Oct 1;49(10):440-445. doi: 10.14745/ccdr.v49i10a05.
5
Cohort profile: the British Columbia COVID-19 Cohort (BCC19C)-a dynamic, linked population-based cohort.队列资料简介:不列颠哥伦比亚省 COVID-19 队列(BCC19C)——一个动态的、基于人群的关联队列。
Front Public Health. 2024 Feb 21;12:1248905. doi: 10.3389/fpubh.2024.1248905. eCollection 2024.
6
Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada.在加拿大不列颠哥伦比亚省,德尔塔和奥密克戎变异株流行期间,不同年龄组因首次感染 SARS-CoV-2 而住院和死亡的风险。
CMAJ. 2023 Oct 30;195(42):E1427-E1439. doi: 10.1503/cmaj.230721.
7
Effect of vaccination on COVID-19 hospitalizations and mortality.疫苗接种对新冠病毒感染住院率和死亡率的影响。
J Bras Pneumol. 2023 Sep 18;49(4):e20230254. doi: 10.36416/1806-3756/e20230254.